BMJ Best Practice
最后审核时间: 十月 2018
最近更新时间: 八月 2018

小结

定义

病史和查体

关键诊断因素

  • 存在危险因素
  • 疼痛(前葡萄膜炎)
  • 视力下降
  • 粘连

其他诊断因素

  • 流泪
  • 畏光
  • 飞蚊症
  • 红眼但无分泌物

危险因素

  • 关节、肠道或皮肤的炎症性疾病
  • 人类白细胞抗原-B27 (human leucocyte antigen-B27, HLA-B27) 检测阳性
  • 眼部外伤
  • 年龄在 30-40 岁之间

诊断性检查

需要考虑的检查

  • 全血细胞计数 (FBC)
  • 红细胞沉降率 (ESR)
  • C 反应蛋白 (CRP)
  • FTA-ABS、VDRL 以及 RPR
全部具体信息

治疗流程

贡献者

President

Connecticut Uveitis Foundation

Associate Clinical Professor

Yale University

New Haven

Eye Disease Consultants

Hartford

CT

利益冲突披露
JJH declares that he has no competing interests.

Uveitis and Retina Specialist

Medical Eye Center of New Hampshire

Manchester

NH

利益冲突披露
ME declares that he has no competing interests.

Dr John J. Huang and Dr Max Elia would like to gratefully acknowledge Dr Richard Gale, Dr Zsolt Varga, Dr Victor L. Perez, and Dr Carlos A. Medina, the previous contributors to this monograph. RG, ZV, VLP, and CAM declare that they have no competing interests.

同行评议专家 查看所有

Assistant Professor

Ophthalmology

Mount Sinai Hospital

New York

NY

利益冲突披露
JA declares that she has no competing interests.

Director of Ophthalmology

Alfred Hospital

Melbourne

Australia

利益冲突披露
AJH has been reimbursed by Novartis, the manufacturer of Lucentis, for lecture fees. AJH's employer, the Alfred Hospital, has received research funding from Novartis, the manufacturer of Lucentis, and from Bayer, the manufacturer of Eylea.

Chairman

Department of Ophthalmology

The University of Texas Health Science Center at San Antonio

San Antonio

TX

利益冲突披露
DAJ declares that he has no competing interests.

使用此内容应接受我们的免责声明